DIABETE TYPE 2
Clinical trials for DIABETE TYPE 2 explained in plain language.
Never miss a new study
Get alerted when new DIABETE TYPE 2 trials appear
Sign up with your email to follow new studies for DIABETE TYPE 2, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Three dates a day: sweet surprise for diabetes control?
Disease control Not yet recruitingThis study looks at whether eating 3 dates each day for 8 weeks can improve blood sugar control and reduce oxidative stress in people with well-controlled type 2 diabetes. Researchers will replace a portion of carbs in the diet with dates to see if it helps without raising blood …
Matched conditions: DIABETE TYPE 2
Phase: NA • Sponsor: University Tunis El Manar • Aim: Disease control
Last updated May 17, 2026 06:22 UTC
-
New approach aims to better control blood pressure and blood sugar in rural seniors
Disease control Not yet recruitingThis study tests a new way to manage care for older adults (ages 60-74) who have both high blood pressure and type 2 diabetes in rural China. About 960 participants from community health centers will receive either the new integrated care package or standard care. The goal is to …
Matched conditions: DIABETE TYPE 2
Phase: NA • Sponsor: Nanchang University • Aim: Disease control
Last updated May 17, 2026 06:18 UTC
-
Could a probiotic boost brain and body health in diabetes?
Disease control Not yet recruitingThis study tests whether a daily probiotic called LP-LDL® can improve cholesterol, blood sugar, and thinking skills in 210 adults with prediabetes or diabetes (type 1 or 2) who also have high cholesterol or triglycerides. Participants will take either the probiotic or a placebo f…
Matched conditions: DIABETE TYPE 2
Phase: NA • Sponsor: Aalborg University • Aim: Disease control
Last updated May 14, 2026 12:03 UTC
-
New study aims to find best Add-On drug for type 2 diabetes
Disease control Not yet recruitingThis study compares two diabetes medications, empagliflozin and glimepiride, in adults with type 2 diabetes whose blood sugar is not well controlled with metformin and sitagliptin. The goal is to see which drug helps patients achieve better blood sugar levels without causing low …
Matched conditions: DIABETE TYPE 2
Phase: PHASE4 • Sponsor: Chong Kun Dang Pharmaceutical • Aim: Disease control
Last updated May 13, 2026 15:59 UTC
-
New drug aims to shrink fatty liver in diabetes patients
Disease control Not yet recruitingThis early-stage study tests whether a drug called Henggliejin can improve fatty liver in people with type 2 diabetes and nonalcoholic fatty liver disease (NAFLD). About 149 adults will take the drug for 48 weeks. Researchers will check liver health using a simple blood test call…
Matched conditions: DIABETE TYPE 2
Phase: EARLY_PHASE1 • Sponsor: Fujian Medical University Union Hospital • Aim: Disease control
Last updated May 08, 2026 12:01 UTC
-
Gut stem cell shot aims to tame diabetes
Disease control Not yet recruitingThis early study tests if injecting a person's own fat stem cells into the upper gut can safely improve blood sugar control in type 2 diabetes. About 15 adults with poorly controlled diabetes will receive the treatment through an endoscope. The main goal is to check safety, but r…
Matched conditions: DIABETE TYPE 2
Phase: NA • Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS • Aim: Disease control
Last updated May 07, 2026 18:41 UTC
-
New study tests diet and therapy combo to soothe diabetic nerve pain
Symptom relief Not yet recruitingThis study looks at whether a special therapy called Intraneural Facilitation (INF) and a diet plan can reduce pain and improve walking in people with type 2 diabetes and nerve damage. About 60 adults aged 35 to 85 with moderate to severe nerve pain will be split into three group…
Matched conditions: DIABETE TYPE 2
Phase: NA • Sponsor: Loma Linda University • Aim: Symptom relief
Last updated May 12, 2026 13:43 UTC
-
New study to uncover how diabetes drugs calm the Heart's nerves
Knowledge-focused Not yet recruitingThis study will monitor 150 adults with type 2 diabetes, some with heart failure or kidney disease, to see how a class of drugs called SGLT2 inhibitors affects the balance between the 'fight or flight' and 'rest and digest' nervous systems. Participants will wear a heart monitor …
Matched conditions: DIABETE TYPE 2
Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS • Aim: Knowledge-focused
Last updated May 17, 2026 06:15 UTC